This trial will compare the efficacy of a second-generation LMA to endotracheal intubation in 148 patients with a BMI of 30-49.9 kg/m2.
1 Primary · 4 Secondary · Reporting Duration: Intra-operatively
Active Control
300 Total Participants · 2 Treatment Groups
Primary Treatment: Second-Generation LMA · No Placebo Group · N/A
Age 18 - 80 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 100.0% |
MD Anderson Cancer Center | 100.0% |
Met criteria | 100.0% |
3+ | 100.0% |